Dr. James Robert Overlease III, MD

Dr. Overlease practices at Novamed Surgery Center of Warrensburg (B Burkarth Rd) in Warrensburg, Missouri.

Dr. Overlease's NPI, 1154362077, was assigned on June 10, 2006. Dr. Overlease graduated from University of Texas Medical School at Houston in 2003. Dr. Overlease holds Missouri license 0841684.

Dr. Overlease's primary practice is Novamed Surgery Center of Warrensburg (B Burkarth Rd), at 506 B Burkarth Road, Warrensburg, MO 64093. The practice phone is (660) 747-1888.

Dr. Overlease's primary practice is Novamed Surgery Center of Warrensburg (B Burkarth Rd) in Warrensburg, Missouri. Dmand AI also links Dr. Overlease to 4 group practices and clinics and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Overlease practices, 5 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Overlease's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Overlease is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Overlease's licenses on file in 2 states: Missouri and Kansas.

CMS data shows 3,744 Medicare services from Dr. Overlease across 16 procedure codes in 2024, for 1,109 Medicare patients. Medicare paid $247,928 for them.

CMS counts 1,109 Medicare patients who saw Dr. Overlease in 2024. The largest group is 75 to 84, with 499 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Overlease's median patient age at 76, with 59% women.

In 2024, Dr. Overlease wrote 5,813 Medicare Part D claims for 970 patients. 76% of them were for generic drugs. CMS names the drug for 5,709 of them, across 25 drugs with 11 or more claims each, at $374,091 in total drug cost. In 2023, CMS named 5,157 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Overlease for performance year 2024, reported individually. Dr. Overlease accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 253 procedures of cataract surgery by Dr. Overlease, more than 87% of the clinicians it reports for that procedure.

CMS Open Payments shows 164 general payments to Dr. Overlease from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $1,066.

Dr. Overlease graduated from University of Texas Medical School at Houston in 2003.